• Home
  • Medichem S.A.

Medichem S.A.

About Medichem S.A.

Medichem is a vertically integrated pharmacompan specialized in the development and manufacture of APIs and FDFs for the global generics industry.  
Our portfolio offers about 45 APIs and 20 FDFs, including highly potent products, as well as a wide range of services, ranging from R&D development to contract manufacturing and licensing. It is also a world leader in Chlorhexidine & Octenidine products. 
The group boasts of 50 years of experience in the sector, and guarantees the highest standards of quality, operational excellence and respect for the environmen...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • ES
  • 2015
    On CPHI since
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
  • +34 93 477 6440
  • Website
  • Fructuós Gelabert, 6-8, Conata II Building, 5th floor, 08970, Sant Joan Despi, Barcelona, Spain
Show contact info Hide contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from Medichem S.A. (5)

  • SUGAMMADEX SODIUM FDF

    Product SUGAMMADEX SODIUM FDF

    SOLUTION FOR INJECTION ANESTHESIA FDF
  • PRUCALOPRIDE succinate FDF

    Product PRUCALOPRIDE succinate FDF

    film-coated tablets - chronic constipation FDF
  • DAPTOMYCIN FDF

    Product DAPTOMYCIN FDF

    Medichem S.A. offers wide range of finished dosage forms for licencing which includes Daptomycin. Indication: Antibiotic. Pharmaceutical form: Powder for solution for injection or infusion in glass vial. Strength: 350 mg, 500 mg. Dossier status: EU filed.
  • RIVAROXABAN FDF

    Product RIVAROXABAN FDF

    Medichem S.A. offers wide range of pharmaceutical APIs and FDF which includes Rivaroxaban. Indication: Antithrombotic. Contact us for more information.
  • SUNITINIB MALATE FDF

    Product SUNITINIB MALATE FDF

    Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sunitinib Malate. Indication: Kidney Cancer/ GIT Stromal Tumors. Pharmaceutical form: Capsules. Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg. Dossier status: EU filed.

Medichem S.A. Resources (2)